Assessing a healthcare bundle designed to improve the management of patients with artery disease. The CHABLIS Study

Not Applicable

Completed

• Conditions: Peripheral arterial disease; Circulatory System; Peripheral vascular disease, unspecified

• Registration Number: ISRCTN13202085
• Lead Sponsor: niversity of Leicester

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/37881303/ (added 29/11/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36690397/ embedded qualitative feasibility results (added 29/11/2023) Preprint results see attached file ISRCTN13202085 preprint results.pdf (added 09/04/2024) 2024 Results article in https://doi.org/10.1186/s40814-024-01445-z, (added 09/04/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-27
• Study Completion: 2022-06-04
• Last Update Posted: 22 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Patients:
1. Adult (>18 years of age) patient with incapacitating intermittent claudication or chronic limb threatening ischaemia (Rutherford stages 3–6)
2. Referred to secondary care, either in a clinic or for inpatient treatment
3. Willing and able to give written informed consent for participation in the study
4. Access to a telephone or computer with internet access (for those taking part in remote interviews/consensus meeting)

Healthcare professionals:
5. Healthcare professionals who provide care to patients with have symptomatic peripheral arterial disease

Exclusion Criteria

1. Female participants who are pregnant, lactating or planning a pregnancy during the course of the study
2. Patients who do not have the capacity to consent for themselves
3. Patients with a life-limiting condition whereby conservative management is most appropriate
4. Patients with asymptomatic peripheral arterial disease

Study & Design

• Study Type: Observational
• Study Design: Not specified